UROONCOLOGY - Original Article

Evaluation of germ-cell neoplasia in situ entity in testicular tumors

Volume 45 · Issue 6 Publish Date: October 11, 2019
Full Text PDF
DOI
Mehmet Akyüz
Department of Urology, Health Sciences University Haydarpaşa Numune Training and Research Hospital, İstanbul, Turkey
Metin İshak Öztürk
Department of Urology, Health Sciences University Haydarpaşa Numune Training and Research Hospital, İstanbul, Turkey
Ahmet Ürkmez
Department of Urology, Health Sciences University Haydarpaşa Numune Training and Research Hospital, İstanbul, Turkey
Orhan Koca
Department of Urology, Health Sciences University Haydarpaşa Numune Training and Research Hospital, İstanbul, Turkey
Ramazan Topaktaş
Department of Urology, Health Sciences University Haydarpaşa Numune Training and Research Hospital, İstanbul, Turkey
Akyüz, M., Öztürk, M. İshak, Ürkmez, A., Koca, O., & Topaktaş, R. (2019). Evaluation of germ-cell neoplasia in situ entity in testicular tumors. Urology Research and Practice, 45(6), 418–422. https://doi.org/10.5152/tud.2018.48855
Full Text Full Text PDF

Abstract

Objective: Germ-cell neoplasia in situ (GCNIS) is accepted as the precursor of the testicular tumors. The aim in our study is to compare the lymphadenopathy and metastasis parameters in patients diagnosed with testicular tumor with or without GCNIS based on pathological evaluation.

Material and methods: Data from 108 patients who underwent orchiectomy for testicular tumor between January 2007 and December 2014 in our clinic were retrospectively analyzed and included in the study. Patients were divided into two groups based on the pathology reports as GCNIS or not. Groups were compared regarding lymphadenopathy, metastasis, tumor marker levels, tumor size, lymphovascular invasion, rete testis invasion. Mann-Whitney U test was used for statistical evaluation.

Results: Mean age of the patients included in the study were calculated as 34.6±9.3 years. Eighty-five (78.7%) patients had GCNIS, while 23 (21.3%) of them had not. In terms of metastasis, lymphadenopathy, marker levels, tumor size, lymphovascular invasion and rete testis invasion, no statistical significant difference were observed between two groups (p>0.05).

Conclusion: In our study, no statistical significant difference was observed on the prognostic factors concerning the GCNIS entity, which is reported frequently in testicular tumor pathologies. For presently these findings show us that GCNIS cannot be used as a prognostic factor.

Cite this article as: Akyüz M, Topaktaş R, Ürkmez A, Koca O, Öztürk Mİ. Evaluation of germ-cell neoplasia in situ entity in testicular tumors. Turk J Urol 2019; 45(6): 418-22.

Similar Articles

Article Info
Published In
Journal Urology Research and Practice
Volume / Issue Volume 45 · Issue 6
Pages 418-422
History
Published Online October 11, 2019
Copyright
Affiliations
Mehmet Akyüz
Department of Urology, Health Sciences University Haydarpaşa Numune Training and Research Hospital, İstanbul, Turkey
Metin İshak Öztürk
Department of Urology, Health Sciences University Haydarpaşa Numune Training and Research Hospital, İstanbul, Turkey
Ahmet Ürkmez
Department of Urology, Health Sciences University Haydarpaşa Numune Training and Research Hospital, İstanbul, Turkey
Orhan Koca
Department of Urology, Health Sciences University Haydarpaşa Numune Training and Research Hospital, İstanbul, Turkey
Ramazan Topaktaş
Department of Urology, Health Sciences University Haydarpaşa Numune Training and Research Hospital, İstanbul, Turkey
Cite this Article
Akyüz, M., Öztürk, M. İshak, Ürkmez, A., Koca, O., & Topaktaş, R. (2019). Evaluation of germ-cell neoplasia in situ entity in testicular tumors. Urology Research and Practice, 45(6), 418–422. https://doi.org/10.5152/tud.2018.48855
Outlines